CYTOKINETICS, INCORPORATED Research and Development Expense
CYTOKINETICS, INCORPORATED (CYTK) reported Research and Development Expense of $97.81 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- CYTOKINETICS, INCORPORATED research and development expense for the quarter ending 2026-06-30 was $97.81M, a 11.20% decline year-over-year.
- CYTOKINETICS, INCORPORATED research and development expense for the quarter ending 2026-03-31 was $95.53M, a 2.79% decline year-over-year.
- CYTOKINETICS, INCORPORATED research and development expense for the quarter ending 2025-12-31 was $104.40M, a 11.50% increase year-over-year.
- CYTOKINETICS, INCORPORATED research and development expense for the quarter ending 2025-09-30 was $99.23M, a 17.28% increase year-over-year.
- CYTOKINETICS, INCORPORATED research and development expense for fiscal 2025 was $416.03M, a 22.57% increase from fiscal 2024.
- CYTOKINETICS, INCORPORATED research and development expense for fiscal 2024 was $339.41M, a 2.81% increase from fiscal 2023.
- CYTOKINETICS, INCORPORATED research and development expense for fiscal 2023 was $330.12M, a 37.09% increase from fiscal 2022.
- CYTOKINETICS, INCORPORATED research and development expense for fiscal 2022 was $240.81M, a 50.57% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 167 month | Research and Development Expense 170 month | Research and Development Expense 173 month | Research and Development Expense 176 month | Research and Development Expense 179 month | Research and Development Expense 182 month | Research and Development Expense 185 month | Research and Development Expense 188 month | Research and Development Expense 191 month | Research and Development Expense 194 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $97.81M 10-Q · filed 2026-08-06 | $193.33M 10-Q · filed 2026-08-06 | $297.73M derived: sum of 3 quarters · filed 2026-08-06 | $396.96M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2026-03-31 | $95.53M 10-Q · filed 2026-05-05 | $199.92M derived: sum of 2 quarters · filed 2026-05-05 | $299.16M derived: sum of 3 quarters · filed 2026-05-05 | $409.29M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2025-12-31 | $104.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $203.63M derived: sum of 2 quarters · filed 2026-02-26 | $313.77M derived: sum of 3 quarters · filed 2026-08-06 | $416.03M 10-K · filed 2026-02-26 | |||||||||||||
| 2025-09-30 | $99.23M 10-Q · filed 2025-11-05 | $209.37M derived: sum of 2 quarters · filed 2026-08-06 | $311.63M 10-Q · filed 2025-11-05 | $401.26M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2025-06-30 | $110.14M 10-Q · filed 2026-08-06 | $112.55M 10-Q · filed 2025-08-07 | $208.40M 10-Q · filed 2026-08-06 | $212.40M 10-Q · filed 2025-08-07 | $302.03M derived: sum of 3 quarters · filed 2026-08-06 | $386.64M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||
| 2025-03-31 | $98.26M 10-Q · filed 2026-05-05 | $99.84M 10-Q · filed 2025-05-06 | $191.89M derived: sum of 2 quarters · filed 2026-05-05 | $276.50M derived: sum of 3 quarters · filed 2026-05-05 | $356.10M derived: sum of 4 quarters · filed 2026-05-05 | ||||||||||||
| 2024-12-31 | $93.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $178.24M derived: sum of 2 quarters · filed 2026-02-26 | $257.84M derived: sum of 3 quarters · filed 2026-02-26 | $339.41M 10-K · filed 2026-02-26 | |||||||||||||
| 2024-09-30 | $84.61M 10-Q · filed 2025-11-05 | $164.21M derived: sum of 2 quarters · filed 2025-11-05 | $245.78M 10-Q · filed 2025-11-05 | $330.75M derived: sum of 4 quarters · filed 2026-02-26 | |||||||||||||
| 2024-06-30 | $79.60M 10-Q · filed 2025-08-07 | $161.17M 10-Q · filed 2025-08-07 | $246.14M derived: sum of 3 quarters · filed 2026-02-26 | $328.68M derived: sum of 4 quarters · filed 2026-02-26 | |||||||||||||
| 2024-03-31 | $81.57M 10-Q · filed 2025-05-06 | $166.55M derived: sum of 2 quarters · filed 2026-02-26 | $249.08M derived: sum of 3 quarters · filed 2026-02-26 | $332.27M derived: sum of 4 quarters · filed 2026-02-26 | |||||||||||||
| 2023-12-31 | $84.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $167.51M derived: sum of 2 quarters · filed 2026-02-26 | $250.70M derived: sum of 3 quarters · filed 2026-02-26 | $330.12M 10-K · filed 2026-02-26 | |||||||||||||
| 2023-09-30 | $82.53M 10-Q · filed 2024-11-07 | $165.73M derived: sum of 2 quarters · filed 2024-11-07 | $245.15M 10-Q · filed 2024-11-07 | $320.17M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||||||
| 2023-06-30 | $83.19M 10-Q · filed 2024-08-09 | $162.62M 10-Q · filed 2024-08-09 | $237.63M derived: sum of 3 quarters · filed 2025-02-27 | $300.37M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||||||
| 2023-03-31 | $79.42M 10-Q · filed 2024-05-10 | $154.44M derived: sum of 2 quarters · filed 2025-02-27 | $217.17M derived: sum of 3 quarters · filed 2025-02-27 | $274.30M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||||||
| 2022-12-31 | $75.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $137.75M derived: sum of 2 quarters · filed 2025-02-27 | $194.88M derived: sum of 3 quarters · filed 2025-02-27 | $240.81M 10-K · filed 2025-02-27 | |||||||||||||
| 2022-09-30 | $62.73M 10-Q · filed 2023-11-03 | $119.86M derived: sum of 2 quarters · filed 2023-11-03 | $165.79M 10-Q · filed 2023-11-03 | $209.29M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||||||
| 2022-06-30 | $57.13M 10-Q · filed 2023-08-03 | $103.06M 10-Q · filed 2023-08-03 | $146.56M derived: sum of 3 quarters · filed 2024-02-28 | $195.00M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||||||
| 2022-03-31 | $45.94M 10-Q · filed 2023-05-05 | $89.43M derived: sum of 2 quarters · filed 2024-02-28 | $137.87M derived: sum of 3 quarters · filed 2024-02-28 | $174.31M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||||||
| 2021-12-31 | $43.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $91.93M derived: sum of 2 quarters · filed 2024-02-28 | $128.38M derived: sum of 3 quarters · filed 2024-02-28 | $159.94M 10-K · filed 2024-02-28 | |||||||||||||
| 2021-09-30 | $48.44M 10-Q · filed 2022-11-04 | $84.88M derived: sum of 2 quarters · filed 2022-11-04 | $116.44M 10-Q · filed 2022-11-04 | $145.66M derived: sum of 4 quarters · filed 2023-03-01 | |||||||||||||
| 2021-06-30 | $36.44M 10-Q · filed 2022-08-05 | $68.00M 10-Q · filed 2022-08-05 | $97.22M derived: sum of 3 quarters · filed 2023-03-01 | $121.43M derived: sum of 4 quarters · filed 2023-03-01 | |||||||||||||
| 2021-03-31 | $31.56M 10-Q · filed 2022-05-06 | $60.78M derived: sum of 2 quarters · filed 2023-03-01 | $84.98M derived: sum of 3 quarters · filed 2023-03-01 | $106.77M derived: sum of 4 quarters · filed 2023-03-01 | |||||||||||||
| 2020-12-31 | $29.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $53.42M derived: sum of 2 quarters · filed 2023-03-01 | $75.21M derived: sum of 3 quarters · filed 2023-03-01 | $96.95M 10-K · filed 2023-03-01 | |||||||||||||
| 2020-09-30 | $24.20M 10-Q · filed 2021-11-05 | $45.99M derived: sum of 2 quarters · filed 2021-11-05 | $67.73M 10-Q · filed 2021-11-05 | $86.06M derived: sum of 4 quarters · filed 2022-02-25 | |||||||||||||
| 2020-06-30 | $21.79M 10-Q · filed 2021-08-06 | $43.53M 10-Q · filed 2021-08-06 | $61.86M derived: sum of 3 quarters · filed 2022-02-25 | $82.09M derived: sum of 4 quarters · filed 2022-02-25 | |||||||||||||
| 2020-03-31 | $21.74M 10-Q · filed 2021-05-07 | $40.07M derived: sum of 2 quarters · filed 2022-02-25 | $60.30M derived: sum of 3 quarters · filed 2022-02-25 | $84.32M derived: sum of 4 quarters · filed 2022-02-25 | |||||||||||||
| 2019-12-31 | $18.33M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $38.56M derived: sum of 2 quarters · filed 2022-02-25 | $62.58M derived: sum of 3 quarters · filed 2022-02-25 | $86.13M 10-K · filed 2022-02-25 | |||||||||||||
| 2019-09-30 | $20.23M 10-Q · filed 2020-11-06 | $44.25M derived: sum of 2 quarters · filed 2020-11-06 | $67.79M 10-Q · filed 2020-11-06 | $91.07M derived: sum of 4 quarters · filed 2021-02-26 | |||||||||||||
| 2019-06-30 | $24.02M 10-Q · filed 2020-08-07 | $47.56M 10-Q · filed 2020-08-07 | $70.84M derived: sum of 3 quarters · filed 2021-02-26 | $92.23M derived: sum of 4 quarters · filed 2021-02-26 | |||||||||||||
| 2019-03-31 | $23.55M 10-Q · filed 2020-05-08 | $46.82M derived: sum of 2 quarters · filed 2021-02-26 | $68.21M derived: sum of 3 quarters · filed 2021-02-26 | $89.80M derived: sum of 4 quarters · filed 2021-02-26 | |||||||||||||
| 2018-12-31 | $23.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $44.67M derived: sum of 2 quarters · filed 2021-02-26 | $66.25M derived: sum of 3 quarters · filed 2021-02-26 | $89.14M 10-K · filed 2021-02-26 | |||||||||||||
| 2018-09-30 | $21.39M 10-Q · filed 2019-11-01 | $42.97M derived: sum of 2 quarters · filed 2019-11-01 | $65.86M 10-Q · filed 2019-11-01 | $91.36M derived: sum of 4 quarters · filed 2019-11-01 | |||||||||||||
| 2018-06-30 | $21.58M 10-Q · filed 2019-08-09 | $43.72M 10-Q · filed 2019-08-09 | $69.97M derived: sum of 3 quarters · filed 2019-08-09 | $94.92M derived: sum of 4 quarters · filed 2019-08-09 | |||||||||||||
| 2018-03-31 | $22.14M 10-Q · filed 2019-05-09 | $48.39M derived: sum of 2 quarters · filed 2019-05-09 | $73.33M derived: sum of 3 quarters · filed 2019-05-09 | $93.14M derived: sum of 4 quarters · filed 2019-05-09 | |||||||||||||
| 2017-12-31 | $26.25M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $51.20M derived: sum of 2 quarters · filed 2019-03-07 | $71.01M derived: sum of 3 quarters · filed 2019-03-07 | $90.30M 10-K · filed 2019-03-07 | |||||||||||||
| 2017-09-30 | $24.95M 10-Q · filed 2018-11-09 | $44.76M derived: sum of 2 quarters · filed 2018-11-09 | $64.05M 10-Q · filed 2018-11-09 | $82.82M derived: sum of 4 quarters · filed 2018-11-09 | |||||||||||||
| 2017-06-30 | $19.81M 10-Q · filed 2018-08-07 | $39.10M 10-Q · filed 2018-08-07 | $57.87M derived: sum of 3 quarters · filed 2018-08-07 | $75.74M derived: sum of 4 quarters · filed 2018-08-07 | |||||||||||||
| 2017-03-31 | $19.29M 10-Q · filed 2018-05-10 | $38.06M derived: sum of 2 quarters · filed 2018-05-10 | $55.93M derived: sum of 3 quarters · filed 2018-05-10 | $65.65M derived: sum of 4 quarters · filed 2018-05-10 | |||||||||||||
| 2016-12-31 | $18.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $36.64M derived: sum of 2 quarters · filed 2018-03-05 | $46.36M derived: sum of 3 quarters · filed 2018-03-05 | $59.90M 10-K · filed 2018-03-05 | |||||||||||||
| 2016-09-30 | $17.86M 10-Q · filed 2017-11-03 | $19.34M 10-Q · filed 2016-11-03 | $27.59M derived: sum of 2 quarters · filed 2017-11-03 | $41.12M 10-Q · filed 2017-11-03 | $42.60M 10-Q · filed 2016-11-03 | $54.37M derived: sum of 4 quarters · filed 2018-03-05 | |||||||||||
| 2016-06-30 | $9.72M 10-Q · filed 2017-08-04 | $23.26M 10-Q · filed 2017-08-04 | $36.51M derived: sum of 3 quarters · filed 2018-03-05 | $48.06M derived: sum of 4 quarters · filed 2018-03-05 | |||||||||||||
| 2016-03-31 | $13.53M 10-Q · filed 2017-05-04 | $26.78M derived: sum of 2 quarters · filed 2018-03-05 | $38.34M derived: sum of 3 quarters · filed 2018-03-05 | $50.98M derived: sum of 4 quarters · filed 2018-03-05 | |||||||||||||
| 2015-12-31 | $13.25M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-05 | $24.81M derived: sum of 2 quarters · filed 2018-03-05 | $37.44M derived: sum of 3 quarters · filed 2018-03-05 | $46.40M 10-K · filed 2018-03-05 | |||||||||||||
| 2015-09-30 | $11.56M 10-Q/A · filed 2016-12-15 | $24.19M derived: sum of 2 quarters · filed 2016-12-15 | $33.15M 10-Q/A · filed 2016-12-15 | $41.93M derived: sum of 4 quarters · filed 2017-03-06 | |||||||||||||
| 2015-06-30 | $12.64M 10-Q · filed 2016-08-04 | $21.59M 10-Q · filed 2016-08-04 | $30.37M derived: sum of 3 quarters · filed 2017-03-06 | $41.79M derived: sum of 4 quarters · filed 2017-03-06 | |||||||||||||
| 2015-03-31 | $8.96M 10-Q · filed 2016-05-05 | $17.73M derived: sum of 2 quarters · filed 2017-03-06 | $29.16M derived: sum of 3 quarters · filed 2017-03-06 | $40.89M derived: sum of 4 quarters · filed 2017-03-06 | |||||||||||||
| 2014-12-31 | $8.78M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $20.20M derived: sum of 2 quarters · filed 2017-03-06 | $31.94M derived: sum of 3 quarters · filed 2017-03-06 | $44.43M 10-K · filed 2017-03-06 | |||||||||||||
| 2014-09-30 | $11.42M 10-Q · filed 2015-11-05 | $23.16M derived: sum of 2 quarters · filed 2015-11-05 | $35.65M 10-Q · filed 2015-11-05 | $49.47M derived: sum of 4 quarters · filed 2016-03-03 | |||||||||||||
| 2014-06-30 | $11.74M 10-Q · filed 2015-08-05 | $24.23M 10-Q · filed 2015-08-05 | $38.05M derived: sum of 3 quarters · filed 2016-03-03 | $51.50M derived: sum of 4 quarters · filed 2016-03-03 | |||||||||||||
| 2014-03-31 | $12.49M 10-Q · filed 2015-05-04 | $26.31M derived: sum of 2 quarters · filed 2016-03-03 | $39.76M derived: sum of 3 quarters · filed 2016-03-03 | $52.11M derived: sum of 4 quarters · filed 2016-03-03 | |||||||||||||
| 2013-12-31 | $13.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $27.27M derived: sum of 2 quarters · filed 2016-03-03 | $39.62M derived: sum of 3 quarters · filed 2016-03-03 | $49.45M 10-K · filed 2016-03-03 | |||||||||||||
| 2013-09-30 | $13.45M 10-Q · filed 2014-11-06 | $25.79M derived: sum of 2 quarters · filed 2014-11-06 | $35.63M 10-Q · filed 2014-11-06 | $45.48M derived: sum of 4 quarters · filed 2015-03-06 | $523.74M 10-Q · filed 2013-11-06 | ||||||||||||
| 2013-06-30 | $12.35M 10-Q · filed 2014-08-07 | $22.18M 10-Q · filed 2014-08-07 | $32.04M derived: sum of 3 quarters · filed 2015-03-06 | $40.84M derived: sum of 4 quarters · filed 2015-03-06 | $510.30M 10-Q · filed 2013-08-07 | ||||||||||||
| 2013-03-31 | $9.83M 10-Q · filed 2014-05-07 | $19.69M derived: sum of 2 quarters · filed 2015-03-06 | $28.49M derived: sum of 3 quarters · filed 2015-03-06 | $36.73M derived: sum of 4 quarters · filed 2015-03-06 | $497.95M 10-Q · filed 2013-05-08 | ||||||||||||
| 2012-12-31 | $9.86M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-06 | $18.66M derived: sum of 2 quarters · filed 2015-03-06 | $26.90M derived: sum of 3 quarters · filed 2015-03-06 | $35.64M 10-K · filed 2015-03-06 | $488.12M 10-K · filed 2013-03-15 | ||||||||||||
| 2012-09-30 | $8.80M 10-Q · filed 2013-11-06 | $17.04M derived: sum of 2 quarters · filed 2013-11-06 | $25.79M 10-Q · filed 2013-11-06 | $34.38M derived: sum of 4 quarters · filed 2014-03-07 | $478.26M 10-Q · filed 2012-11-07 | ||||||||||||
| 2012-06-30 | $8.24M 10-Q · filed 2013-08-07 | $16.99M 10-Q · filed 2013-08-07 | $25.59M derived: sum of 3 quarters · filed 2014-03-07 | $34.48M derived: sum of 4 quarters · filed 2014-03-07 | $469.46M 10-Q · filed 2012-08-06 | ||||||||||||
| 2012-03-31 | $8.74M 10-Q · filed 2013-05-08 | $17.34M derived: sum of 2 quarters · filed 2014-03-07 | $26.23M derived: sum of 3 quarters · filed 2014-03-07 | $36.75M derived: sum of 4 quarters · filed 2014-03-07 | $461.22M 10-Q · filed 2012-05-04 | ||||||||||||
| 2011-12-31 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $17.49M derived: sum of 2 quarters · filed 2014-03-07 | $28.00M derived: sum of 3 quarters · filed 2014-03-07 | $37.18M 10-K · filed 2014-03-07 | $452.47M 10-K · filed 2012-03-13 | ||||||||||||
| 2011-09-30 | $8.89M 10-Q · filed 2012-11-07 | $19.40M derived: sum of 2 quarters · filed 2012-11-07 | $28.58M 10-Q · filed 2012-11-07 | $37.74M derived: sum of 4 quarters · filed 2013-03-15 | $443.87M 10-Q · filed 2011-11-04 | ||||||||||||
| 2011-06-30 | $10.51M 10-Q · filed 2012-08-06 | $19.69M 10-Q · filed 2012-08-06 | $28.85M derived: sum of 3 quarters · filed 2013-03-15 | $38.40M derived: sum of 4 quarters · filed 2013-03-15 | $434.98M 10-Q · filed 2011-08-04 | ||||||||||||
| 2011-03-31 | $9.18M 10-Q · filed 2012-05-04 | $18.34M derived: sum of 2 quarters · filed 2013-03-15 | $27.89M derived: sum of 3 quarters · filed 2013-03-15 | $38.12M derived: sum of 4 quarters · filed 2013-03-15 | |||||||||||||
| 2010-12-31 | $9.16M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $18.71M derived: sum of 2 quarters · filed 2013-03-15 | $28.94M derived: sum of 3 quarters · filed 2013-03-15 | $38.01M 10-K · filed 2013-03-15 | |||||||||||||
| 2010-09-30 | $9.55M 10-Q · filed 2011-11-04 | $19.78M derived: sum of 2 quarters · filed 2011-11-04 | $28.85M 10-Q · filed 2011-11-04 | ||||||||||||||
| 2010-06-30 | $10.24M 10-Q · filed 2011-08-04 | $19.30M 10-Q · filed 2011-08-04 | |||||||||||||||
| 2009-12-31 | $39.84M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |